The new 23andMe experience reflects almost two years of work to create a new product with a redesigned site and better functionality. The service now includes reports that meet FDA standards for being scientifically and clinically valid. Customers in the US who purchase on or after October 21, 2015 will receive personalized genetic health reports that include carrier status*, wellness, and trait reports.
For more information about the service, see www.23andme.com/service.
*Our tests can be used to determine carrier status in adults, but cannot determine if you have two copies of the genetic variant. Each test is most relevant for people of certain ethnicities. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.